表紙:医薬品ドラッグデリバリー:世界市場規模予測(2020年~2028年)
市場調査レポート
商品コード
1021480

医薬品ドラッグデリバリー:世界市場規模予測(2020年~2028年)

Pharmaceutical Drug Delivery - Global Market Outlook (2020-2028)

出版日: | 発行: Stratistics Market Research Consulting | ページ情報: 英文 150+ Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.72円
医薬品ドラッグデリバリー:世界市場規模予測(2020年~2028年)
出版日: 2021年07月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 150+ Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の医薬品ドラッグデリバリーの市場規模は、2020年に1兆4,305億米ドルとなり、予測期間中に9.1%のCAGRで成長し、2028年までに2兆8,713億5,000万米ドルに達すると予測されています。

医療費の増加、医療に対する関心や意識の高まり、ドラッグデリバリー分野の研究に対する政府の支援などの要因が、市場の成長を促しています。しかし、針刺し事故のリスクが市場の成長を阻害しています。

当レポートでは医薬品ドラッグデリバリーの世界市場を調査し、市場の概要、市場の成長要因および阻害要因の分析、市場機会、Covid-19の影響、投与経路・アプリケーション・エンドユーザー・地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

  • 促進要因
  • 抑制要因
  • 市場機会
  • 脅威
  • アプリケーション分析
  • エンドユーザー分析
  • 新興市場
  • Covid-19の影響

第4章 ポーターズのファイブフォース分析

第5章 投与経路別

  • 注射可能なドラッグデリバリー
    • 自己注射装置
    • 従来の注射装置
  • 経口ドラッグデリバリー
    • 液体経口薬
    • 半固形経口薬
    • 固形経口薬
  • 眼のドラッグデリバリー
    • 眼の半固体製剤
    • 接眼レンズ
    • 眼液製剤
  • 局所ドラッグデリバリー
    • 局所用液体製剤
    • 局所経皮吸収剤
    • 局所半固体製剤
    • 局所用固形製剤
  • 経鼻ドラッグデリバリー
    • 点鼻スプレー
    • 鼻用の粉
    • 鼻用ジェル
    • 点鼻液
  • 肺のドラッグデリバリー
    • ドライパウダー吸入器
    • 定量吸入器
    • ネブライザー
  • 埋め込み型ドラッグデリバリー
    • パッシブ埋め込み型ドラッグデリバリー
    • アクティブ埋め込み型ドラッグデリバリー
  • 経粘膜ドラッグデリバリー
    • 経口製剤
    • その他

第6章 アプリケーション別

  • 心血管疾患
  • 呼吸器疾患
  • 感染症
  • 糖尿病
  • 中枢神経系障害
  • 自己免疫疾患
  • その他
    • 内分泌障害
    • 眼科疾患

第7章 エンドユーザー別

  • 病院
  • 診断センター
  • 外来手術センター/診療所
  • 在宅ケア

第8章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他欧州
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他アジア太平洋地域
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他南米
  • 中東とアフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他中東およびアフリカ

第9章 主な発展

  • 契約、パートナーシップ、コラボレーション、ジョイントベンチャー
  • 買収と合併
  • 新製品の発売
  • 拡張
  • その他の重要な戦略

第10章 企業プロファイル

  • Teva Pharmaceuticals
  • Sanofi
  • Pfizer, Inc.
  • Bristol-Myers Squibb
  • Novartis AG
  • Merck & Co., Inc.
  • Becton
  • Amgen
  • F. Hoffman-La Roche
  • Eli Lilly and Company
  • Dickinson and Company
  • Antares Pharma, Inc
  • Boehringer Ingelheim
  • Johnson & Johnson, Inc.
  • GlaxoSmithKline plc
  • Bayer AG
  • AstraZeneca
  • Genmab A/S
  • AbbVie
  • 3M Company
  • Gilead Sciences, Inc.
図表

List of Tables

  • Table 1 Global Pharmaceutical Drug Delivery Market Outlook, By Region (2019-2028) ($MN)
  • Table 2 Global Pharmaceutical Drug Delivery Market Outlook, By Route of Administration (2019-2028) ($MN)
  • Table 3 Global Pharmaceutical Drug Delivery Market Outlook, By Injectable Drug Delivery (2019-2028) ($MN)
  • Table 4 Global Pharmaceutical Drug Delivery Market Outlook, By Self-Injection Devices (2019-2028) ($MN)
  • Table 5 Global Pharmaceutical Drug Delivery Market Outlook, By Conventional Injection Devices (2019-2028) ($MN)
  • Table 6 Global Pharmaceutical Drug Delivery Market Outlook, By Oral Drug Delivery (2019-2028) ($MN)
  • Table 7 Global Pharmaceutical Drug Delivery Market Outlook, By Liquid Oral Drugs (2019-2028) ($MN)
  • Table 8 Global Pharmaceutical Drug Delivery Market Outlook, By Semi-Solid Oral Drugs (2019-2028) ($MN)
  • Table 9 Global Pharmaceutical Drug Delivery Market Outlook, By Solid Oral Drugs (2019-2028) ($MN)
  • Table 10 Global Pharmaceutical Drug Delivery Market Outlook, By Ocular Drug Delivery (2019-2028) ($MN)
  • Table 11 Global Pharmaceutical Drug Delivery Market Outlook, By Ocular Semi-Solid Formulations (2019-2028) ($MN)
  • Table 12 Global Pharmaceutical Drug Delivery Market Outlook, By Ocular Ocular Devices (2019-2028) ($MN)
  • Table 13 Global Pharmaceutical Drug Delivery Market Outlook, By Ocular Liquid Formulations (2019-2028) ($MN)
  • Table 14 Global Pharmaceutical Drug Delivery Market Outlook, By Topical Drug Delivery (2019-2028) ($MN)
  • Table 15 Global Pharmaceutical Drug Delivery Market Outlook, By Topical Liquid Formulations (2019-2028) ($MN)
  • Table 16 Global Pharmaceutical Drug Delivery Market Outlook, By Topical Transdermal Products (2019-2028) ($MN)
  • Table 17 Global Pharmaceutical Drug Delivery Market Outlook, By Topical Semi-Solid Formulations (2019-2028) ($MN)
  • Table 18 Global Pharmaceutical Drug Delivery Market Outlook, By Topical Solid Formulations (2019-2028) ($MN)
  • Table 19 Global Pharmaceutical Drug Delivery Market Outlook, By Nasal Drug Delivery (2019-2028) ($MN)
  • Table 20 Global Pharmaceutical Drug Delivery Market Outlook, By Nasal Sprays (2019-2028) ($MN)
  • Table 21 Global Pharmaceutical Drug Delivery Market Outlook, By Nasal Powders (2019-2028) ($MN)
  • Table 22 Global Pharmaceutical Drug Delivery Market Outlook, By Nasal Gels (2019-2028) ($MN)
  • Table 23 Global Pharmaceutical Drug Delivery Market Outlook, By Nasal Drops (2019-2028) ($MN)
  • Table 24 Global Pharmaceutical Drug Delivery Market Outlook, By Pulmonary Drug Delivery (2019-2028) ($MN)
  • Table 25 Global Pharmaceutical Drug Delivery Market Outlook, By Dry Powder Inhaler (2019-2028) ($MN)
  • Table 26 Global Pharmaceutical Drug Delivery Market Outlook, By Metered-Dose Inhaler (2019-2028) ($MN)
  • Table 27 Global Pharmaceutical Drug Delivery Market Outlook, By Nebulizers (2019-2028) ($MN)
  • Table 28 Global Pharmaceutical Drug Delivery Market Outlook, By Implantable Drug Delivery (2019-2028) ($MN)
  • Table 29 Global Pharmaceutical Drug Delivery Market Outlook, By Passive Implantable Drug Delivery (2019-2028) ($MN)
  • Table 30 Global Pharmaceutical Drug Delivery Market Outlook, By Active Implantable Drug Delivery (2019-2028) ($MN)
  • Table 31 Global Pharmaceutical Drug Delivery Market Outlook, By Transmucosal Drug Delivery (2019-2028) ($MN)
  • Table 32 Global Pharmaceutical Drug Delivery Market Outlook, By Oral Formulations (2019-2028) ($MN)
  • Table 33 Global Pharmaceutical Drug Delivery Market Outlook, By Other Transmucosal Drug Delivery Technologies (2019-2028) ($MN)
  • Table 34 Global Pharmaceutical Drug Delivery Market Outlook, By Application (2019-2028) ($MN)
  • Table 35 Global Pharmaceutical Drug Delivery Market Outlook, By Cardiovascular Diseases (2019-2028) ($MN)
  • Table 36 Global Pharmaceutical Drug Delivery Market Outlook, By Respiratory Diseases (2019-2028) ($MN)
  • Table 37 Global Pharmaceutical Drug Delivery Market Outlook, By Cancer (2019-2028) ($MN)
  • Table 38 Global Pharmaceutical Drug Delivery Market Outlook, By Infectious Diseases (2019-2028) ($MN)
  • Table 39 Global Pharmaceutical Drug Delivery Market Outlook, By Diabetes (2019-2028) ($MN)
  • Table 40 Global Pharmaceutical Drug Delivery Market Outlook, By Central Nervous System Disorders (2019-2028) ($MN)
  • Table 41 Global Pharmaceutical Drug Delivery Market Outlook, By Autoimmune Diseases (2019-2028) ($MN)
  • Table 42 Global Pharmaceutical Drug Delivery Market Outlook, By Other Applications (2019-2028) ($MN)
  • Table 43 Global Pharmaceutical Drug Delivery Market Outlook, By Endocrine Disorders (2019-2028) ($MN)
  • Table 44 Global Pharmaceutical Drug Delivery Market Outlook, By Ophthalmic Disorders (2019-2028) ($MN)
  • Table 45 Global Pharmaceutical Drug Delivery Market Outlook, By End User (2019-2028) ($MN)
  • Table 46 Global Pharmaceutical Drug Delivery Market Outlook, By Hospitals (2019-2028) ($MN)
  • Table 47 Global Pharmaceutical Drug Delivery Market Outlook, By Diagnostic Centers (2019-2028) ($MN)
  • Table 48 Global Pharmaceutical Drug Delivery Market Outlook, By Ambulatory Surgery Centers/Clinics (2019-2028) ($MN)
  • Table 49 Global Pharmaceutical Drug Delivery Market Outlook, By Home Care Settings (2019-2028) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

目次
Product Code: SMRC20762

According to Stratistics MRC, the Global Pharmaceutical Drug Delivery Market is accounted for $1,430.50 billion in 2020 and is expected to reach $2,871.35 billion by 2028 growing at a CAGR of 9.1% during the forecast period. Factors such as rise in healthcare expenditure, growing concern and awareness about healthcare, and government support for research in the field of drug delivery are driving the growth of the market. However, risk of needlestick injuries is hampering the growth of the market.

A pharmaceutical drug delivery is a formulation or a device, which is employed for the administration of a therapeutic substance into the body. It functions by deploying medications to specifically targeted parts of the body by the aid of a medium, which can control the administration of the therapy by the means of either a physiological or chemical trigger. It is used to improve the efficacy and safety of an administered drug by controlling the rate, time, and site of release of drug in the body.

Based on the route of administration, the injectable drug delivery segment is anticipated to expand at a rapid pace during the forecast period owing to the increasing prevalence of chronic diseases, growing demand for biosimilar products, and low cost of devices. By geography, North America is going to have high growth during the forecast period which can be attributed to the increasing patient compliance to innovative drug delivery technologies and the presence of a large number of prominent players in this region.

Some of the key players profiled in the Pharmaceutical Drug Delivery Market include Teva Pharmaceuticals, Sanofi, Pfizer, Inc., Bristol-Myers Squibb, Novartis AG , Merck & Co., Inc., Becton, Amgen, F. Hoffman-La Roche, Eli Lilly and Company, Dickinson and Company, Antares Pharma, Inc, Boehringer Ingelheim, Johnson & Johnson, Inc., GlaxoSmithKline plc, Bayer AG, AstraZeneca, Genmab A/S, AbbVie, 3M Company, and Gilead Sciences, Inc.

Routes of Administration Covered:

  • Injectable Drug Delivery
  • Oral Drug Delivery
  • Ocular Drug Delivery
  • Topical Drug Delivery
  • Nasal Drug Delivery
  • Pulmonary Drug Delivery
  • Implantable Drug Delivery
  • Transmucosal Drug Delivery

Applications Covered:

  • Cardiovascular Diseases
  • Respiratory Diseases
  • Cancer
  • Infectious Diseases
  • Diabetes
  • Central Nervous System Disorders
  • Autoimmune Diseases
  • Other Applications

End Users Covered:

  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgery Centers/Clinics
  • Home Care Settings

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2019, 2020, 2021, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Pharmaceutical Drug Delivery Market, By Route of Administration

  • 5.1 Introduction
  • 5.2 Injectable Drug Delivery
    • 5.2.1 Self-Injection Devices
      • 5.2.1.1 Wearable Injectors
      • 5.2.1.2 Pen Injectors
      • 5.2.1.3 Needle-Free Injectors
      • 5.2.1.4 Autoinjectors
    • 5.2.2 Conventional Injection Devices
      • 5.2.2.1 Product
      • 5.2.2.1.1 Prefilled Syringes
      • 5.2.2.1.2 Fillable Syringes
      • 5.2.2.2 Usability
      • 5.2.2.2.1 Disposable Syringes
      • 5.2.2.2.2 Reusable Syringes
      • 5.2.2.3 Material
      • 5.2.2.3.1 Plastic
      • 5.2.2.3.2 Glass
  • 5.3 Oral Drug Delivery
    • 5.3.1 Liquid Oral Drugs
      • 5.3.1.1 Solutions
      • 5.3.1.2 Syrups
    • 5.3.2 Semi-Solid Oral Drugs
      • 5.3.2.1 Elixirs
      • 5.3.2.2 Emulsions
      • 5.3.2.3 Gels
    • 5.3.3 Solid Oral Drugs
      • 5.3.3.1 Tablets
      • 5.3.3.2 Powders
      • 5.3.3.3 Pills
      • 5.3.3.4 Capsules
  • 5.4 Ocular Drug Delivery
    • 5.4.1 Ocular Semi-Solid Formulations
      • 5.4.1.1 Eye Ointments
      • 5.4.1.2 Gels
    • 5.4.2 Ocular Ocular Devices
      • 5.4.2.1 Ocular Inserts
      • 5.4.2.2 Drug-Coated Contact Lenses
    • 5.4.3 Ocular Liquid Formulations
      • 5.4.3.1 Liquid Sprays
      • 5.4.3.2 Eye Drops
  • 5.5 Topical Drug Delivery
    • 5.5.1 Topical Liquid Formulations
      • 5.5.1.1 Suspensions
      • 5.5.1.2 Solutions
    • 5.5.2 Topical Transdermal Products
      • 5.5.2.1 Transdermal Gels
      • 5.5.2.2 Transdermal Patches
    • 5.5.3 Topical Semi-Solid Formulations
      • 5.5.3.1 Pastes
      • 5.5.3.2 Ointments
      • 5.5.3.3 Lotions
      • 5.5.3.4 Gels
      • 5.5.3.5 Creams
    • 5.5.4 Topical Solid Formulations
      • 5.5.4.1 Powders
      • 5.5.4.2 Suppositories
  • 5.6 Nasal Drug Delivery
    • 5.6.1 Nasal Sprays
    • 5.6.2 Nasal Powders
    • 5.6.3 Nasal Gels
    • 5.6.4 Nasal Drops
  • 5.7 Pulmonary Drug Delivery
    • 5.7.1 Dry Powder Inhaler
    • 5.7.2 Metered-Dose Inhaler
    • 5.7.3 Nebulizers
      • 5.7.3.1 Ultrasonic Nebulizers
      • 5.7.3.2 Soft Mist Nebulizers
      • 5.7.3.3 Jet Nebulizers
  • 5.8 Implantable Drug Delivery
    • 5.8.1 Passive Implantable Drug Delivery
    • 5.8.2 Active Implantable Drug Delivery
  • 5.9 Transmucosal Drug Delivery
    • 5.9.1 Oral Formulations
      • 5.9.1.1 Sublingual Drug Delivery
      • 5.9.1.2 Buccal Drug Delivery
    • 5.9.2 Other Transmucosal Drug Delivery Technologies
      • 5.9.2.1 Vaginal Transmucosal Drug Delivery
      • 5.9.2.2 Rectal Transmucosal Drug Delivery

6 Global Pharmaceutical Drug Delivery Market, By Application

  • 6.1 Introduction
  • 6.2 Cardiovascular Diseases
  • 6.3 Respiratory Diseases
  • 6.4 Cancer
  • 6.5 Infectious Diseases
  • 6.6 Diabetes
  • 6.7 Central Nervous System Disorders
  • 6.8 Autoimmune Diseases
  • 6.9 Other Applications
    • 6.9.1 Endocrine Disorders
    • 6.9.2 Ophthalmic Disorders

7 Global Pharmaceutical Drug Delivery Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Diagnostic Centers
  • 7.4 Ambulatory Surgery Centers/Clinics
  • 7.5 Home Care Settings

8 Global Pharmaceutical Drug Delivery Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Teva Pharmaceuticals
  • 10.2 Sanofi
  • 10.3 Pfizer, Inc.
  • 10.4 Bristol-Myers Squibb
  • 10.5 Novartis AG
  • 10.6 Merck & Co., Inc.
  • 10.7 Becton
  • 10.8 Amgen
  • 10.9 F. Hoffman-La Roche
  • 10.10 Eli Lilly and Company
  • 10.11 Dickinson and Company
  • 10.12 Antares Pharma, Inc
  • 10.13 Boehringer Ingelheim
  • 10.14 Johnson & Johnson, Inc.
  • 10.15 GlaxoSmithKline plc
  • 10.16 Bayer AG
  • 10.17 AstraZeneca
  • 10.18 Genmab A/S
  • 10.19 AbbVie
  • 10.20 3M Company
  • 10.21 Gilead Sciences, Inc.